Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6743 |
(E/Z)-4-Hydroxytamoxifen
4-羟基他莫昔芬,(E/Z)-4-羟基他莫昔芬,Afimoxifene,4-Hydroxytamoxifen |
Estrogen Receptor/ERR; Estrogen/progestogen Receptor | Endocrinology/Hormones |
(E/Z)-4-Hydroxytamoxifen (Afimoxifene) 是 tamoxifen 的活性代谢物和选择性雌激素受体(ER)调节剂,广泛用于乳腺癌的治疗和化学预防治疗。 | |||
T4420 |
4-Hydroxytamoxifen
ICI 79280,(Z)-4-hydroxy Tamoxifen,4-羟基他莫昔芬,trans-4-Hydroxytamoxifen |
Estrogen Receptor/ERR; Estrogen/progestogen Receptor | Endocrinology/Hormones |
4-Hydroxytamoxifen (ICI 79280) 是 Tamoxifen 的活性代谢产物,是一种雌激素受体调节剂 (SERM),具有选择性和口服有效性。4-Hydroxytamoxifen 具有抗肿瘤活性,可用于乳腺癌的研究。 | |||
T71578 | Endoxifen mesylate | ||
Endoxifen, also known as N-desmethyl-4-hydroxytamoxifen, is a chemical that is under development for estrogen receptor-positive breast cancer. It is also being evaluated as an antipsychotic for treatment of mania and other psychotic disorders. Endoxifen is a nonsteroidal selective estrogen receptor modulator (SERM) of the triphenylethylene group. It is an active metabolite of tamoxifen and has been found to be effective in patients that have failed previous hormonal therapies (tamoxifen, aromat... |